tradingkey.logo
tradingkey.logo
Search

Iovance Biotherapeutics Appoints Matthew Rosinack As Interim Principal Financial Officer

ReutersJul 3, 2025 8:10 PM
facebooktwitterlinkedin

- Iovance Biotherapeutics Inc IOVA.O:

  • IOVANCE BIOTHERAPEUTICS INC - MATTHEW ROSINACK APPOINTED INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI